Melissa Cheu

820 total citations
14 papers, 530 citations indexed

About

Melissa Cheu is a scholar working on Immunology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Melissa Cheu has authored 14 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Physiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Melissa Cheu's work include Asthma and respiratory diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (3 papers). Melissa Cheu is often cited by papers focused on Asthma and respiratory diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (3 papers). Melissa Cheu collaborates with scholars based in United States, Switzerland and France. Melissa Cheu's co-authors include Saloumeh K Fischer, John G. Matthews, Elaine Murray, Dana McClintock, Wendy S. Putnam, Yanan Zheng, Julie Olsson, Michael Noonan, Nicola A. Hanania and Jonathan Corren and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Thorax.

In The Last Decade

Melissa Cheu

14 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa Cheu United States	7	247	185	177	152	133	14	530
Takafumi Minami Japan	15	74 0.3×	151 0.8×	153 0.9×	192 1.3×	40 0.3×	68	572
Winifred Werther United States	13	55 0.2×	145 0.8×	161 0.9×	27 0.2×	226 1.7×	27	568
Takao Katsube Japan	9	79 0.3×	84 0.5×	148 0.8×	29 0.2×	19 0.1×	17	451
J. M. G. Bonfrer Netherlands	14	27 0.1×	103 0.6×	255 1.4×	81 0.5×	129 1.0×	25	670
Yongjing Cheng China	11	38 0.2×	88 0.5×	86 0.5×	26 0.2×	48 0.4×	35	316
Ch. Salmon France	14	167 0.7×	112 0.6×	132 0.7×	28 0.2×	40 0.3×	59	589
Valerie Relias United States	11	12 0.0×	182 1.0×	139 0.8×	34 0.2×	68 0.5×	32	463
Akihide Masumoto Japan	12	30 0.1×	47 0.3×	131 0.7×	30 0.2×	21 0.2×	42	453
Homayoun Moslehi United States	6	38 0.2×	134 0.7×	180 1.0×	15 0.1×	22 0.2×	6	692
Julie A. Di Paolo United States	9	15 0.1×	168 0.9×	100 0.6×	28 0.2×	55 0.4×	17	521

Countries citing papers authored by Melissa Cheu

Since Specialization

Citations

This map shows the geographic impact of Melissa Cheu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Cheu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Cheu more than expected).

Fields of papers citing papers by Melissa Cheu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Cheu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Cheu. The network helps show where Melissa Cheu may publish in the future.

Co-authorship network of co-authors of Melissa Cheu

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Cheu. A scholar is included among the top collaborators of Melissa Cheu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Cheu. Melissa Cheu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cheu, Melissa, et al.. (2024). Successful Development of Nonclinical Anti-Drug Antibody Assays to Support Zinpentraxin Alfa Reproductive Toxicology Studies. The AAPS Journal. 26(1). 16–16. 1 indexed citations

Setiadi, Audi, Gizette Sperinde, Melissa Cheu, et al.. (2023). The Development and Characterization of a Highly Sensitive Mature TGFβ3 Assay to Evaluate Anti-TGFβ3 Target Engagement. The AAPS Journal. 25(1). 21–21. 2 indexed citations

Jamois, Candice, Leonid Gibiansky, Melissa Cheu, et al.. (2022). Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis. Clinical and Translational Science. 15(9). 2172–2183. 3 indexed citations

Yadav, Rajbharan, Siddharth Sukumaran, Tanja S. Zabka, et al.. (2022). Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies. Pharmaceutics. 14(5). 970–970. 5 indexed citations

Zhu, Rui, Ryan Owen, Justin Wilkins, et al.. (2021). Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps. Pulmonary Pharmacology & Therapeutics. 71. 102080–102080. 2 indexed citations

Ferl, Gregory Z., Arthur E. Reyes, Liping Sun, et al.. (2018). A Preclinical Population Pharmacokinetic Model for Anti‐CD20/CD3 T‐Cell‐Dependent Bispecific Antibodies. Clinical and Translational Science. 11(3). 296–304. 23 indexed citations

Fischer, Saloumeh K, Melissa Cheu, Kun Peng, et al.. (2016). Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material. The AAPS Journal. 19(1). 254–263. 85 indexed citations

Zafra, Christina L. Zuch de, Avi Ashkenazi, Walter C. Darbonne, et al.. (2016). Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey. Cell Death and Disease. 7(8). e2338–e2338. 14 indexed citations

Cowan, Kyra J., Xiaoying Gao, Lawren C. Wu, et al.. (2016). Fit-For-Purpose Biomarker Immunoassay Qualification and Validation: Three Case Studies. Bioanalysis. 8(22). 2329–2340. 6 indexed citations

10.

Mills, John R., Divi Cornec, Surendra Dasari, et al.. (2016). Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis. Analytical Chemistry. 88(12). 6317–6325. 28 indexed citations

11.

Hanania, Nicola A., Michael Noonan, Jonathan Corren, et al.. (2015). Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 70(8). 748–756. 299 indexed citations

12.

Baker, Dana Lee, Kun Peng, Melissa Cheu, & Saloumeh K Fischer. (2013). Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Current Medical Research and Opinion. 30(5). 913–922. 2 indexed citations

13.

Putnam, Wendy S., Jing Li, Jonas Häggström, et al.. (2008). Use of Quantitative Pharmacology in the Development of HAE1, a High-Affinity Anti-IgE Monoclonal Antibody. The AAPS Journal. 10(2). 425–30. 33 indexed citations

14.

Herbst, Roy S., David S. Mendelson, Sabine Eckhardt, et al.. (2006). Apo2L/TRAIL pharmacokinetics in a phase 1a trial in advanced cancer and lymphoma. Journal of Clinical Oncology. 24(18_suppl). 3047–3047. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact